A Study to Evaluate the Efficacy and Safety of Renexin CR in Patients With Acute Non-cardioembolic Ischemic Stroke
Clinical trial NCT05445895 · COMPLETED
Trial details
- NCT number
- NCT05445895
- Sponsor
- SK Chemicals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-16
- Primary completion
- 2025-10-02
- Enrollment
- 483
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.